Bioinformatics analysis of the human surfaceome reveals new targets for a variety of tumor types

It is estimated that 10 to 20% of all genes in the human genome encode cell surface proteins and due to their subcellular localization these proteins represent excellent targets for cancer diagnosis and therapeutics. Therefore, a precise characterization of the surfaceome set in different types of t...

Descripción completa

Detalles Bibliográficos
Autores: Fonseca, André L., Silva, Vandeclécio Lira da, Fonseca, Marbella M., Meira, Isabella Tanus Job e, Silva, Thayná Emília Oliveira, Kroll, José Eduardo, Ribeiro-dos-Santos, André M., Freitas, Cléber R., Furtado, Raimundo, Souza, Jorge Estefano Santana de, Ferreira, Beatriz Stransky, Souza, Sandro José de
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:Brasil
Institución:Universidade Federal do Rio Grande do Norte (UFRN)
Repositorio:Repositório Institucional da UFRN
Idioma:inglés
OAI Identifier:oai:repositorio.ufrn.br:123456789/29572
Acceso en línea:https://repositorio.ufrn.br/jspui/handle/123456789/29572
Access Level:acceso abierto
Palabra clave:Cancer genes
Tumor Types
Descripción
Sumario:It is estimated that 10 to 20% of all genes in the human genome encode cell surface proteins and due to their subcellular localization these proteins represent excellent targets for cancer diagnosis and therapeutics. Therefore, a precise characterization of the surfaceome set in different types of tumor is needed. Using TCGA data from 15 different tumor types and a new method to identify cancer genes, the -score, we identified several potential therapeutic targets within the surfaceome set. This allowed us to expand a previous analysis from us and provided a clear characterization of the human surfaceome in the tumor landscape. Moreover, we present evidence that a three-gene set—WNT5A, CNGA2, and IGSF9B—can be used as a signature associated with shorter survival in breast cancer patients. The data made available here will help the community to develop more efficient diagnostic and therapeutic tools for a variety of tumor types